The levonorgestrel-releasing intrauterine system and endometriosis staging

Gomes MK; Mariana Kefalás Oliveira Gomes; Rui Alberto Ferriani; Ferriani RA; Ana Carolina Japur de Sá Rosa e Silva; Júlio Cesar Rosa e Silva; Júlio César Rosa e Silva; Japur de Sá Rosa e Silva AC; Carolina Sales Vieira; Francisco José Cândido dos Reis

doi:10.1016/j.fertnstert.2006.11.044

The levonorgestrel-releasing intrauterine system and endometriosis staging

Gomes MK, Mariana Kefalás Oliveira Gomes, Rui Alberto Ferriani, Ferriani RA, Ana Carolina Japur de Sá Rosa e Silva, Júlio Cesar Rosa e Silva, Júlio César Rosa e Silva, Japur de Sá Rosa e Silva AC, Carolina Sales Vieira, Francisco José Cândido dos Reis

Fertility and sterility · 2007 · vol. 87(5) , pp. 1231–1234 · doi:10.1016/j.fertnstert.2006.11.044 · PMID:17292364 · W1984572979

article OA: closed CC0 ⤵ 35 in-corpus citations

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the relationship between the levonorgestrel-releasing intrauterine system and endometriosis staging in patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This study aims to determine whether the levonorgestrel-releasing intrauterine system can influence American Society for Reproductive Medicine endometriosis staging scores, as assessed through second-look laparoscopies, and to compare the results with those obtained with a GnRH agonist. Both treatments reduced the extent of pelvic endometriotic lesions in patients with chronic pelvic pain.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Endometriosis Endometriosis Intrauterine Devices, Medicated Levonorgestrel Adolescent Adult Endometriosis Female Follow-Up Studies Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Levonorgestrel Pelvic Pain Pelvic Pain Pelvic Pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
Effect of GnRH analogues on apoptosis and release of interleukin-1 and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis via openalex
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium via openalex
Endometriosis-Related Pelvic Pain: What is the Evidence? via openalex
Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosiss via openalex
Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex
The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex
The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex
The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis via openalex
W6683236057 via openalex
W2053998452 via openalex
W2070900245 via openalex
W2123134517 via openalex
W2125652739 via openalex
W2142447002 via openalex
W2159608759 via openalex
W1978677754 via openalex

Cited by (35)

Source provenance

europepmc: last seen: 2026-07-27T06:15:28.040536+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:15:06.633332+00:00

License: CC0 · commercial use OK

[1] Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex

[2] Effect of GnRH analogues on apoptosis and release of interleukin-1 and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis via openalex

[3] Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium via openalex

[4] Endometriosis-Related Pelvic Pain: What is the Evidence? via openalex

[5] Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosiss via openalex

[6] Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex

[7] Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex

[8] The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex

[9] The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex

[10] The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis via openalex

[11] W6683236057 via openalex

[12] W2053998452 via openalex

[13] W2070900245 via openalex

[14] W2123134517 via openalex

[15] W2125652739 via openalex

[16] W2142447002 via openalex

[17] W2159608759 via openalex

[18] W1978677754 via openalex